Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237935 · ClinicalTrials.gov registry record
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
A clinical trial of Antiplatelet, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 27,960
- Enrollment target
- 1
- Study location
NCT04237935: Completed study of Antiplatelet, sponsored by Brigham and Women's Hospital.
NCT04237935 is a study of Antiplatelet that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 27,960 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04237935, a study of Antiplatelet, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 27,960 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Primary Outcome
Relative hazard of 3-point major adverse cardiovascular events (MACE), i.e., non-fatal myocardial infarction, non-fatal stroke, or all-cause/CV mortality- Please refer to uploaded protocol for full definition due to size limitations.
Conditions Studied
Interventions
- DRUG Ticagrelor 90mg
- DRUG Clopidogrel 75mg
Study Locations (1)
Massachusetts
- Brigham And Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,960 participants |
| Start Date | 2019-09-22 |
| Est. Completion | 2021-02-18 |
What the finished NCT04237935 record still lists
NCT04237935 is an observational study that tracks outcomes without assigning an intervention. Its 27,960 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Antiplatelet appearing as the primary indexed condition, and to 2 interventions - of which Ticagrelor 90mg is the first listed.
NCT04237935 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04237935 about?
NCT04237935 is a clinical study titled "Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04237935?
This trial is currently completed. The enrollment target is 27,960 participants. The study started on 2019-09-22. Estimated completion is 2021-02-18.
What conditions does trial NCT04237935 study?
This clinical trial studies the following conditions: Antiplatelet.
What interventions are being tested in trial NCT04237935?
The interventions under investigation include: Ticagrelor 90mg (DRUG), Clopidogrel 75mg (DRUG).
Who is sponsoring clinical trial NCT04237935?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237935 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI